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Abstract
Background. In Asia, the role of primary care physicians (PCPs) in mental health delivery is not 
clearly defined and what happens to patients following a depressive episode remains poorly 
understood.
Objective. To examine the 12-month naturalistic outcomes of depression in primary care and the 
impact of PCP identification.
Methods. A cohort study was conducted. A  total of 10 179 adults were consecutively recruited 
from the waiting rooms of 59 PCPs across Hong Kong to complete a survey which screened for 
depression. Blinded doctors provided data on their diagnosis and management; 539 screened-
positive and 3819 screened-negative subjects consented to telephone follow-up at 3, 6 and 
12 months. Study instruments included Patient Health Questionnaire-9, Centre for Epidemiologic 
Studies Depression Scale 20 and Short-Form Health Survey Version 2.0 (SF-12v2) and self-reported 
mental health and primary care service use.
Results. 12-month remission rate was 60.31%. PCP detection had no association with remission. 
Identified patients had poorer health-related quality of life (HRQOL) at baseline but a faster rate of 
recovery in SF-12v2 mental component scores. PCP detection was associated with greater mental 
health service use at 12, 26 and 52 weeks, while GP consultation rates were only increased at 12 weeks.
Conclusions. Over 1 year, ~60% of depressed patients experience symptom resolution, while 40% 
continue to suffer a chronic or remitting course of illness. Identification of depression by a PCP 
does not appear to affect remission of mood symptoms at 12 months, but is associated with a 
faster rate of recovery of HRQOL. PCP detection raises GP consultation rates temporarily however 
appears to enable more patients to access mental health services over 12 months.
Key words.  Chinese, cohort study, depressive disorders, Hong Kong, primary care.
Introduction
Depression has been identified as a global public health issue 
including in Hong Kong (1). A recent study conducted in Hong 
Kong’s primary care setting estimated the cross-sectional prev-
alence for moderate to severe depression [defined as Patient 
Health Questionnaire-9 (PHQ-9) score >9] as 10.9%, however 
of these, only 23.1% were diagnosed as having depression by 
the doctor (2).
Primary care is the entry point for most people into the health system 
and primary care physicians (PCPs) are ideally placed to provide care for 
patients with depression. In many Asian settings however, the role of the 
PCP is still poorly defined especially when related to mental health deliv-
ery, and patients can consult specialists without a referral. To date, few 
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studies have examined the longitudinal outcomes and the factors affect-
ing prognosis for primary care depression in Asian health care settings (3).
Hong Kong is a Special Administrative Region of the People’s 
Republic of China. Approximately 95% of the seven million people 
living in Hong Kong are of Chinese descent. Hong Kong has a devel-
oped capitalist economy, with a gross domestic product of US$301.6 
billion of which ~5.5% is spent on health care and ~0.24% on mental 
health (4). It has a two-tiered mixed medical economy. Approximately 
80% of primary care is delivered through a ‘fee-for-service’ private 
sector and 20% through government-funded General Out-Patient 
Clinics which are aimed at caring for the elderly and those with 
chronic diseases. There are currently no statutory post-graduate 
qualifications required for doctors to practice in primary care, and 
in private settings, any patient can seek the care of any doctor (5).
To promote evidence-based decision making, it is essential to 
have current knowledge on the natural course of a disease and the 
impact of care on outcomes in the setting where the health care is 
delivered. In terms of health services research, a study on primary 
care patients rather than on the general population is important as it 
provides information on people who already access the health care 
system and who would be efficient targets for interventions. To help 
fill the knowledge gap which currently exists for this setting, the aim 
of this study was to examine the naturalistic outcomes of patients 
with depressive symptoms and the impact of PCP detection.
The objectives of the study were:
1. To evaluate the 12-month outcomes of patients with screened-
positive depression in terms of symptom severity, health-related 
quality of life (HRQOL) and service use;
2. To identify the factors affecting prognosis;
3. To compare the outcomes of depressed patients who have and 
have not been identified by the PCP.
Methods
A cross-sectional followed by a longitudinal cohort study was con-
ducted (Fig. 1). Baseline recruitment of subjects occurred between 
October 2010 and January 2012. Longitudinal data collection 
occurred between October 2010 and January 2013. The study pro-
tocol and preliminary findings of the cross-sectional study have been 
previously published (2,6). This paper focusses on the findings of the 
cohort study.
Figure 1. Patient recruitment flowchart.
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Setting and subjects
Doctors working in primary care clinics across Hong Kong were 
invited to collaborate as part of a practice-based research network. 
PCPs were initially identified using the mailing list of the Hong Kong 
College of Family Physicians. Reflecting the delivery of primary 
care in Hong Kong, participants consisted of clinicians working 
in private practice, government-funded primary care clinics of the 
Hong Kong Hospital Authority, and non-profit, non-governmental 
organizations.
Details of our subject sampling and recruitment strategy have been 
previously reported (6). In summary, all consecutive, eligible patients 
presenting to the study doctor on one randomly allocated day each 
month over a 12-month recruitment period were approached in the 
waiting room to complete a baseline survey. Patients were excluded if 
they were <18 years, did not speak or understand English, Cantonese 
or Mandarin, had cognitive or communication difficulties, had pre-
viously been recruited to the study, or did not consult the doctor. 
A research assistant was present to administer the survey to those 
with poor literacy or eyesight and to answer any queries. Doctors 
(who were blinded to the depression screening scores) were asked to 
document the patient’s presenting problem, their opinion on whether 
the patient had depression and their management if they had identi-
fied the patient as being depressed. All respondents were invited to 
participate in the 12-month longitudinal follow-up. Those who con-
sented by providing their name and contact details were interviewed 
by telephone at 12, 26 and 52 weeks (Fig. 1).
Study instruments
Questions on socio-demography and co-morbidity were adapted from 
previously performed primary care patient surveys and were asked at 
baseline (7).
At each follow-up time point (12, 26 and 52 weeks), patients’ 
self-reported health and mental health status, and recent service uti-
lization were collected with the following instruments:
PHQ-9 is a nine item questionnaire used to screen, monitor, 
diagnose and measure the severity of depressive symptoms (8). The 
Chinese version has been validated among the Hong Kong general 
population (9). A PHQ-9 cut-off score >9 was used to define a posi-
tive screened case for depressive disorders (10).
Centre for Epidemiologic Studies Depression Scale (CES-D 20) is 
a 20-item scale for measuring the current levels of depressive symp-
toms (11). It has been translated into Chinese and been used locally 
in large population surveys (12). A PHQ-9 score <5 together with a 
CES-D 20 score <16 was used to define remission from depression.
Short-Form Health Survey Version 2.0 (SF-12v2) is a 12-item 
abbreviated version of the SF-36 Health Survey that assesses 
HRQOL (13). It generates two norm-based summary scores, the 
mental component score (MCS) and the physical component score 
(PCS). Each averages at 50 for the general population, with higher 
scores indicating better health. The SF-12v2 has been translated and 
validated for use in Hong Kong’s primary care (14).
Questions on health service use included whether respondents 
had consulted a psychiatrist in the last 3 months; whether they had 
received professional psychological counselling from a GP, psycholo-
gist and social worker in the past 3 months; and asked how many 
times they had seen a GP in the past month.
Ethics
This study received ethics approvals by the Institutional Review 
Board of the University of Hong Kong/Hospital Authority Hong 
Kong West Cluster as well as all relevant regional and intuitional 
review boards.
Data analysis
Using a PHQ-9 score <5 together with a CES-D 20 score <16 to 
define remission from depression, estimation of the remission from 
depression over a 12-month period was made on subjects who 
screened PHQ+ve at baseline with a 95% confidence interval (CI), 
taking into account the design of clustering by practice. Patient and 
doctor factors associated with remission were examined using a non-
linear mixed effects model with logit link taking into account the 
within practice correlation.
Predictive significance of patient and doctor factors on the two 
SF-12v2 component scores at 12-month interval were examined by 
linear mixed effect model. The change of PHQ-9 score and the two 
SF-12v2 component scores among the initially screened PHQ-9 posi-
tive subjects who had and had not been identified with depression 
by study doctor at baseline were compared using mixed models for 
dealing with missing data. A 5% level of significance was used and 
all estimates accompanied by a 95% CI where appropriate.
Proportional differences in health service use between the patient 
subgroups that screened PHQ+ve and PHQ−ve, and in PHQ+ve sub-
jects who were detected and not detected by the doctor were exam-
ined using chi-square tests of independence.
STATA version 12 was used to carry out the analyses.
Results
Participants and recruitment rates
A total of 10 179 subjects were recruited at baseline (response rate 
of 81%). Of these, 4358 consented to participate in the longitudi-
nal study (response rate of 42.8%). Demographic characteristics of 
the baseline subjects, cohort participants and the general population 
(from the Hong Kong 2011 Census) are shown in Table 1. A flow-
chart of subject recruitment and participation is shown in Figure 1.
Remission rate and prognostic factors for 
depression
Among patients who screened PHQ+ve at baseline, the 12-month 
remission rate was 60.31% (95% CI: 54.08–66.53%). Both univari-
able and multivariable of non-linear mixed effects analysis was con-
ducted to examine factors associated with remission. The result of 
multivariable model (Table 2) showed that having ≥2 co-morbidities 
was associated with the lowest likelihood of remission while being 
retired, was the only factor associated with an increased likelihood 
of remission. Baseline PHQ-9 score and doctor detection did not 
have any significant association with remission in both univariable 
and multivariable models. The lack of association between doctor 
detection and remission outcome within each PHQ-9 severity level 
were further confirmed with chi-square tests, all P values >0.2. There 
were no significant doctor factors associated with remission in the 
multivariable analysis.
Patient and doctor factors associated with HRQOL
Univariable and multivariable of linear mixed effects analyses were per-
formed for the two SF-12v2 component scores by including patient fac-
tors as level 1 covariates and doctor factors as level 2 covariates. In the 
multivariable model (Table 2), lower (worse) 12-month SF-12v2 PCS 
were observed in those with no exercise habit; those with at least one 
co-morbidity; those who had seen a western doctor more than twice 
in the past 4 weeks; and those who had seen a Traditional Chinese 
Medicine (TCM) practitioner in the past 4 weeks. Conversely, higher 
(better) 12-month SF-12v2 PCS scores were observed in those who had 
attended a doctor with training in Family Medicine; or who worked in 
 at U
niversity of H
ong K
ong on Septem
ber 3, 2015
http://fam
pra.oxfordjournals.org/
D
ow
nloaded from
 
Outcomes of depression in Hong Kong 291
Table 2. Factors associated with remission and HRQOL at 12 months in the PHQ-9 positive cohort, the multivariable linear mixed effects 
models
Remission (patient 
N = 322, doctor N = 54)
SF-12v2 PCS (patient 
N = 305, doctor N = 54)
SF-12v2 MCS (patient 
N = 305, doctor N = 54)
Odds ratio (95% CI) Coefficient (95% CI) Coefficient (95% C.I.)
Fixed effects
Intercept 2.84 (0.34, 23.50) 56.24* (48.37, 64.12) 54.91* (45.20, 64.62)
Level 1: effects on patient factors
Gender (Male)
 Female 0.77 (0.42, 1.41) −0.83 (−3.10, 1.44) 1.02 (−1.78, 3.82)
Age 0.98 (0.95, 1.00) −0.10 (−0.20, 0.00) 0.02 (−0.10, 0.14)
Ethnicity (Chinese)
 Non-Chinese 1.22 (0.21, 7.01) 4.29 (−4.15, 12.74) −6.54 (−16.95, 3.87)
Table 1. Demographic characteristics of the cohort subjects and the Hong Kong general population
Patient participants Baseline sample (N = 10 179) Follow-up cohort (N = 4358) HK 2011 Census (age ≥18 years)
Gender (n, %)
 Male 4142 (40.7%) 1803 (41.4%) 46.7%
 Female 5763 (56.6%) 2529 (58.0%) 53.3%
 Not indicated 274 (2.7%) 26 (0.6%) –
Age in year (mean ± SD) 49.0 ± 18.1 49.6 ± 17.1 46.58 ± 17.4
Age group (n, %)
 18–24 years 689 (6.8%) 269 (6.2%) 10.5%
 25–34 years 1874 (18.4%) 746 (17.1%) 18.1%
 35–44 years 1719 (16.9%) 741 (17.0%) 18.9%
 45–54 years 1777 (17.5%) 817 (18.7%) 21.5%
 55–64 years 1602 (15.7%) 834 (19.1%) 15.4%
 65+ years 2071 (20.3%) 888 (20.4%) 15.7%
 Not indicated 447 (4.4%) 63 (1.4%) –
Ethnicity (n, %)
 Chinese 9744 (95.7%) 4216 (96.7%) 93.6%
 Non-Chinese 394 (3.9%) 140 (3.2%) 6.4%
 Not indicated 41 (0.4%) 2 (0.1%) –
Household monthly income (n, %)
 ≤HK$5000 1243 (12.2%) 560 (12.8%) 11.1%
 HK$5001–HK$10 000 761 (7.5%) 356 (8.2%) 12.7%
 HK$10 001–HK$20 000 1815 (17.8%) 826 (19.0%) 23.8%
 HK$20 001–HK$30 000 1533 (15.1%) 705 (16.2%) 17.6%
 HK$30 001–HK$40 000 1073 (10.5%) 515 (11.8%) 11.4%
 >HK$40 000 2159 (21.2%) 994 (22.8%) 23.5%
 Not indicated 1595 (15.7%) 402 (9.2%) –
Marital status (n, %)
 Single 2699 (26.5%) 1080 (24.8%) 28.8%
 Married 6059 (59.5%) 2771 (63.6%) 60.1%
 Widowed 773 (7.6%) 330 (7.6%) 6.5%
 Separated/divorced 326 (3.2%) 163 (3.7%) 4.6%
 Not indicated 322 (3.2%) 14 (0.3%) –
Education level (n, %)
 No formal schooling 775 (7.6%) 274 (6.3%) 6.4%
 Primary 1629 (16.0%) 800 (18.4%) 23.1%
 Secondary 4127 (40.5%) 1864 (42.8%) 46.8%
 Tertiary 3325 (32.7%) 1404 (32.2%) 23.8%
 Not indicated 323 (3.2%) 16 (0.4%) –
District of residence (n, %)
 Hong Kong Island 4085 (40.1%) 1873 (43.0%) 18.0%
 Kowloon 2243 (22.0%) 1034 (23.7%) 29.8%
 New Territories 3473 (34.1%) 1431 (32.8%) 52.2%
 Not indicated 378 (3.7%) 20 (0.5%) –
Distributions of household monthly income and education level of the HK 2011 Census results reported above may not be exact due to the use of different 
classification groupings.
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a private setting. Lower (worse) 12-month SF-12v2 MCS were observed 
in those with ≥2 co-morbidities; in those who had consulted a western 
doctor more than twice in the previous 4 weeks; and in those who had 
reported to have taken psychotropic medications in the past 12 months. 
Better 12-month SF-12v2 MCS scores were observed in those who were 
retired in both univariable and multivariable analyses.
Remission (patient 
N = 322, doctor N = 54)
SF-12v2 PCS (patient 
N = 305, doctor N = 54)
SF-12v2 MCS (patient 
N = 305, doctor N = 54)
Odds ratio (95% CI) Coefficient (95% CI) Coefficient (95% C.I.)
Marital status (Married)
 All others 0.80 (0.45, 1.42) −1.84 (−3.96, 0.28) −1.26 (−3.87, 1.35)
Household monthly income (>HK$30 000)
 ≤HK$30 000 1.58 (0.83, 3.00) −1.33 (−3.76, 1.10) 0.92 (−2.08, 3.92)
Education level (Secondary or tertiary education)
 No formal or primary education 0.98 (0.46, 2.07) −1.87 (−4.58, 0.83) 0.98 (−2.36, 4.31)
Working status (Employed)
 Unemployed 0.26 (0.04, 1.62) −3.44 (−8.79, 1.91) −5.54 (−12.13, 1.06)
 Retired 3.40* (1.29, 9.00) −2.54 (−6.15, 1.08) 5.98* (1.52, 10.43)
 House-maker 0.79 (0.33, 1.85) −1.01 (−4.11, 2.10) −2.40 (−6.22, 1.43)
 Student 1.15 (0.29, 4.59) 1.12 (−3.77, 6.01) −1.19 (−7.21, 4.84)
Smoking (Non-smoker)
 Smoker 0.63 (0.29, 1.37) 1.14 (−1.69, 3.96) −2.73 (−6.22, 0.76)
Drinking (Non-drinker)
 Drinker 1.46 (0.65, 3.28) −1.15 (−4.14, 1.84) 1.51 (−2.18, 5.20)
Exercise (With exercise)
 No exercise 1.24 (0.71, 2.15) −2.55* (−4.57, −0.53) 2.35 (−0.14, 4.85)
Number of co-morbidity (0)
 1 0.52 (0.27, 1.02) −2.85* (−5.45, −0.24) −0.53 (−3.74, 2.69)
 ≥2 0.31* (0.15, 0.64) −3.44* (−6.15, −0.73) −3.50* (−6.84, −0.16)
Family history of mental illness (No)
 Yes 0.88 (0.44, 1.78) 0.98 (−1.62, 3.58) 2.22 (−0.99, 5.42)
Seen a western doctor in past 4 weeks (No)
 Once or twice 1.01 (0.59, 1.73) −1.94 (−3.98, 0.10) −1.95 (−4.47, 0.57)
 More than twice 0.48 (0.20, 1.12) −9.57* (−12.63, −6.51) −4.88* (−8.65, −1.11)
Seen a TCM practitioner in past 4 weeks (No)
 Yes 0.48* (0.24, 0.96) −3.39* (−5.96, −0.83) −2.65 (−5.81, 0.51)
District of residence (Hong Kong)
 Kowloon 0.91 (0.31, 2.70) −0.65 (−4.80, 3.51) 0.23 (−4.90, 5.36)
 New Territories 0.53 (0.19, 1.48) −1.02 (−5.08, 3.04) −1.58 (−6.59, 3.43)
Diagnosis of depression by doctor at baseline (No)
 Yes 0.90 (0.47, 1.72) 0.62 (−1.75, 2.99) −0.61 (−3.53, 2.32)
Take psychotropic drugs in the past 1 year (No)
 Yes 0.70 (0.39, 1.24) 0.77 (−1.38, 2.93) −3.89* (−6.54, −1.23)
PHQ-9 score at baseline 1.00 (0.93, 1.08) −0.24 (−0.51, 0.03) −0.30 (−0.63, 0.04)
Level 2: effects on doctor factors
Gender (Male)
 Female 0.71 (0.35, 1.43) 0.30 (−2.33, 2.93) −1.55 (−4.80, 1.69)
Age 1.00 (0.97, 1.03) 0.04 (−0.07, 0.16) −0.01 (−0.15, 0.12)
District of practice (Hong Kong)
 Kowloon 0.96 (0.31, 2.94) 0.65 (−3.65, 4.94) −2.18 (−7.47, 3.12)
 New Territories 1.43 (0.47, 4.28) −1.12 (−5.41, 3.17) 1.20 (−4.08, 6.49)
Previous education and training (None)
 Family Medicine training 1.70 (0.74, 3.90) 4.83* (1.67, 7.99) 2.10 (−1.80, 6.00)
 Diploma in Psychological Medicine 0.98 (0.40, 2.40) 1.96 (−1.40, 5.33) −0.91 (−5.06, 3.24)
 Both of the above 1.97 (0.57, 6.75) 4.68* (0.19, 9.16) 3.17 (−2.36, 8.70)
System setting (Public)
 Private 2.33 (0.95, 5.71) 4.29* (0.87, 7.72) 3.00 (−1.23, 7.22)
Error variance
 Intercept Not applicable 0.00 (0.00) 0.00 (0.00)
 Intercept (doctor), variance, standard error 0.00 (0.00) 64.54 (5.23) 98.14 (7.95)
Goodness-of-fit
 Akaike Information Criterion (AIC) 448.13 2206.55 2334.41
 Bayesian Information Criterion (BIC) 576.47 2336.76 2464.62
Estimated with linear mixed effects models. The reference category of each patient and doctor factor was bracketed. For remission model, doctor intraclass cor-
relation coefficient (ICC) = 4.49%. For SF-12v2 PCS model, doctor ICC = 13.17%. For SF-12v2 MCS model, doctor ICC = 0.00%.
*Statistically significant, P value <0.05.
Table 2. Continued
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Change in depressive symptoms and HRQOL scores 
over 12 months
Mean PHQ-9 and SF-12v2 component scores at each follow-up time 
point and changes in scores stratified by detection status are shown 
in Table  3. Without controlling for potential confounding effects, 
subjects who received a diagnosis of depression by the study doctor 
had significantly lower MCS at baseline and higher PHQ-9 scores at 
baseline, 3 and 6 months; however, there was no significant differ-
ence in mean PHQ-9 or mean PCS and MCS between detected and 
undetected groups at 12 months.
Between baseline and 12 months, PCS improved by 10% while 
MCS improved by 30% across the entire PHQ+ve cohort. The 
amount of improvement in PHQ-9 and SF-12v2 PCS was not 
significantly different between detected and undetected groups; 
however, the amount of improvement in SF-12v2 MCS was sig-
nificantly better in those who had been identified by the doctor.
Health service utilization patterns
A comparison of self-reported mental health services uptake and 
GP consultations rates stratified by PHQ and detection status are 
shown in Table  4. Within the PHQ+ve cohort, doctor detection 
was associated with significantly higher rates of mental health 
service use across all time points, while GP consultation rates 
were only raised at 12 weeks but not at 26 or 52 weeks. At each 
time point as well as cumulatively over 12 months more patients 
reported receiving mental health services from a psychiatrist than 
from a GP.
Discussion
To date, there has been no similar wide-scale longitudinal study on 
depression in the Hong Kong adult primary care population and the 
findings of this study contributes to the knowledge base of what hap-
pens to primary care patients in Asian settings following a depressive 
episode.
Symptom resolution and factors affecting remission
A 2014 meta-analysis of remission rates from untreated major depres-
sion in adult primary care patients estimated that around a quarter 
of cases remit within 3 months, a third within 6 months and half 
within 12 months (15). This was consistent with our study’s estimate 
for 12-month naturalistic observation of remission which included 
both treated and untreated cases. Although 60% of subjects reported 
symptom remission, around 40% appear to suffer a chronic or remit-
ting course of illness with persistence of symptoms at 12 months. At 
greatest risk of poor prognosis are depressed patients with multiple 
physical co-morbidities. Similarly, an Australian study examining the 
association between chronic illness, multi-morbidity and depressive 
symptoms in primary care identified a clear dose–response relation-
ship between the number of chronic physical problems and depres-
sive symptoms, probably mediated via the patient’s HRQOL (16).
In many studies, higher baseline depression severity is a predic-
tor for lower rates of remission at 12 months; however, this was not 
observed in our study (17,18). It appears that the trajectory course 
of depressive illness may differ in our setting to those in Western 
health care settings. This may be due to differences in detection or 
Table 3. Comparison of PHQ-9 and SF-12v2 component scores by detection status in the PHQ-9 positive cohort
Doctor detection (−ve) Doctor detection (+ve) P value
Raw scores at each time point
PHQ-9 score (mean ± SD)
 At baseline 13.3 ± 3.2 14.9 ± 4.1 <0.001*
 At 12 weeks 6.4 ± 4.5 8.1 ± 5.5 0.007*
 At 26 weeks 5.8 ± 4.6 7.3 ± 6.3 0.029*
 At 52 weeks 5.2 ± 4.8 6.1 ± 5.6 0.113
SF-12v2 PCS (mean ± SD)
 At baseline 42.8 ± 11.8 41.9 ± 12.2 0.500
 At 12 weeks 43.2 ± 12.2 42.0 ± 12.4 0.505
 At 26 weeks 46.4 ± 10.8 45.5 ± 11.1 0.559
 At 52 weeks 47.6 ± 10.2 45.8 ± 11.9 0.139
SF-12v2 MCS (mean ± SD)
 At baseline 40.0 ± 11.8 31.8 ± 12.3 <0.001*
 At 12 weeks 48.0 ± 10.6 45.5 ± 12.3 0.093
 At 26 weeks 49.3 ± 11.3 46.9 ± 14.0 0.156
 At 52 weeks 50.8 ± 11.0 49.5 ± 11.9 0.325
Difference in scores between baseline and each subsequent follow-up time point
PHQ-9 score (mean ± SD)
 Between baseline and 12 weeks −7.0 ± 5.0 −7.2 ± 6.3 0.785
 Between baseline and 26 weeks −7.3 ± 4.6 −7.4 ± 7.1 0.894
 Between baseline and 52 weeks −8.1 ± 5.5 −8.8 ± 6.6 0.313
SF-12v2 PCS (mean ± SD)
 Between baseline and 12 weeks 0.8 ± 12.2 0.6 ± 12.8 0.904
 Between baseline and 26 weeks 3.3 ± 11.2 4.4 ± 13.7 0.501
 Between baseline and 52 weeks 5.3 ± 11.1 3.8 ± 12.8 0.270
SF-12v2 MCS (mean ± SD)
 Between baseline and 12 weeks 6.9 ± 12.2 14.7 ± 13.5 <0.001*
 Between baseline and 26 weeks 10.0 ± 13.2 15.3 ± 14.5 0.005*
 Between baseline and 52 weeks 10.7 ± 13.4 16.8 ± 14.7 <0.001*
*Significant difference (P < 0.05) between groups by independent t-test.
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treatment rates, or possibly to social or health system factors, and 
requires further exploration.
Of note, retirement appeared to be the only protective patient 
factor associated with better prognosis, possibly reflecting the stress-
ful nature of Hong Kong’s working environment.
Health service use
Mental health service uptake rates were increased over 12 months 
in patients who screened PHQ+ve with identified cases having sig-
nificantly higher uptake rates than those who were not identified. 
PCP detection only raised GP consultation rates temporarily and 
there was no significant difference in GP consultation rates between 
detected and undetected cases at 6 or 12 months. Chinese have been 
identified as chronic under-users of mental health services (19), and 
GP detection appears to enable more patients to access mental health 
care, possibly by helping to overcome some of the personal or social 
stigmas associated with mental health interventions or by providing 
a practical means to access care for those seeking help for their mood 
disturbance. The high rate of psychiatric service use probably reflects 
the poorly defined role of primary care in delivering mental health 
services in our setting, as well as patient’s personal help-seeking pref-
erences (20).
Impact of doctor detection
Although doctor identification did not have any association with 
12-month remission rates, mean PHQ-9 scores, change in PHQ-9 
scores or mean HRQOL PCS over 12  months, the amount of 
improvement to HRQOL MCS was significantly better in those 
who had their depression diagnosed by the doctor with the greatest 
impact occurring within the first 3 months. It appears that doctors 
are better at detecting those with poorer mental HRQOL and are 
more effective at facilitating recovery of patient’s functional status 
than improvement of their mood symptoms.
Although doctor factors did not have any significant associa-
tion with prognosis, there were still some interesting findings noted. 
Firstly, patients who screened positive for depression were more 
likely to consult a younger doctor; however, doctors who were older 
were more likely to identify a patient as being depressed. Secondly, 
screened-negative patients who attended doctors in the public sec-
tor (who were all Family Medicine trained doctors) or doctors with 
training in both Family Medicine and Psychological Medicine had a 
lower risk of developing depression over the year. Similarly, HRQOL 
physical component scores were better at 12 months in those who 
had attended a doctor in the public sector or who had training in 
Family Medicine. It is difficult to prove a causal effect, but it appears 
attending a doctor with training in Family Medicine or with further 
training in psychological medicine, has protective benefits on mental 
well-being.
Strengths and limitations
One of the major strengths of this study was our success in recruiting 
a large number of PCPs to collaborate in this study. There are many 
service delivery options for patients seeking primary care in Hong 
Kong and our wide sampling of practice types captures this diversity. 
Despite this, there were limitations to our sampling strategy.
While we recruited subjects from all three regions of Hong Kong, 
~40% were recruited from Hong Kong Island. Although the three 
regions differ in terms of geographic size, population number and 
socio-economy, a previous study of Hong Kong’s primary care found 
the morbidity patterns to be quite similar territory wide (7).
The cohort sample was self-selected which incurs a risk of 
self-selection bias.
Screening for depression was based on a subjective self-reported 
instrument and was not confirmed by a clinical diagnostic inter-
view which would be the gold standard for diagnosis of depression. 
This study therefore reports the associations between patients with 
depressive symptoms as measured by the PHQ-9 and their longitu-
dinal outcomes, and our findings may not be applicable to subjects 
with depressive symptoms measured or identified by other methods.
Finally, even though detection by PCP appears to have no asso-
ciation with remission rates or HRQOL in our study population, 
there may still be other benefits of PCP detection which this study 
did not measure.
Conclusions
In our setting, most primary care patients who screen positive for 
depression have mild and mostly self-limiting symptoms with 
impaired HRQOL. Over a 12-month period, while ~60% will experi-
ence remission and return to normal levels of HRQOL, 40% appear 
to have a chronic or remitting course of depressive symptomatology. 
Identification of depression by a doctor does not affect prognosis at 
12 months, but is associated with a faster rate of recovery of HRQOL. 
PCP identification of depression is associated with better uptake rates 
for mental health services, but in this setting, it appears that more 
patients receive mental health treatments from a psychiatrist than 
a GP. This study provided estimates for remission and the factors 
influencing remission and HRQOL; however, longer duration studies 
are needed to establish reliable data on chronicity, relapse rates and 
factors associated with relapse. A closer examination of the trajec-
tory paths for depression in this setting is needed to understand why 
patients with more severe symptoms do not have worse outcomes.
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